Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer

NCT02318901 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped PI no longer at sight. Results not collected

Conditions

Advanced Cancer
Breast Cancer
Gastric Cancer
Esophageal Cancer
Colorectal Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Trastuzumab
DRUG: ado-trastuzumab emtansine
DRUG: Cetuximab

Sponsor

Western Regional Medical Center